SJS Investment Consulting’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
SJS Investment Consulting's RMD Position: Q2 2026 in Review
SJS Investment Consulting increased its ResMed (RMD) stake by 962% in Q2 2026, buying an estimated $25.9K and bringing the position to 138 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #682.
SJS Investment Consulting first reported a position in RMD in Q1 2022 and has held it in 17 quarters since. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- SJS Investment Consulting held 138 shares of ResMed worth $26.9K as of Q2 2026.
- SJS Investment Consulting bought 125 ResMed shares in Q2 2026, an estimated $25.9K.
- ResMed made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #682 holding.
- SJS Investment Consulting first reported a position in ResMed in Q1 2022 and has held it in 17 quarters since.
- 485 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.